The protection from HFD-induced insulin resistance in ApoA5 ASO-treated mice could be partially attributed to enhanced peripheral insulin sensitivity, as evidenced by increased peripheral glucose uptake (Fig. 4C) and increased 2-deoxyglucose uptake in skeletal muscle and WAT (Fig. 4D). This evidence concerns the gene APOA5 and Insulin resistance.